Jascayd approval has been granted in Japan and recommended in the European Union for treating adults with two types of pulmonary fibrosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results